Dr. Ron Najafi

Dr. Ron Najafi is the founder and CEO of Emery Pharma, a leading contract research organization (CRO) based in the San Francisco Bay Area. Since its founding in 2011, Emery Pharma has supported the pharmaceutical, biotech, and medical device industries with specialized expertise in bioanalysis, metabolite identification, analytical method development, and pharmaceutical stability testing, including accelerated stability studies. The company also has longstanding experience in antimicrobial drug and device development, conducting studies under both GLP and non-GLP conditions to deliver regulatory-ready data for preclinical and IND-enabling programs.

Emery Pharma is the only contract laboratory in the San Francisco Bay Area equipped with a qualified 400 MHz NMR for GMP-NMR studies, offering detailed structure elucidation, impurity profiling, and lot release testing, alongside LC-MS/MS, high-resolution mass spectrometry (HRMS), and GC-MS platforms.

Dr. Najafi founded Emery Pharma as a subsidiary of NovaBay Pharmaceuticals and took it private in 2015 to broaden its scope. Emery Pharma now serves early-stage biotech startups, mid-sized pharmaceutical companies, and venture-backed innovators across the U.S. and internationally.

Prior to Emery Pharma, Dr. Najafi held leadership roles at Sigma-Aldrich, Rhône-Poulenc Rorer, Applied Biosystems. In 1996, he launched CP Lab Safety following his invention of the ECO Funnel, a laboratory safety device designed to reduce solvent emission